Italy; packages of branded drugs, which became off patent, sold in 2016

This statistic depicts the number of packages of branded drugs, supposed to become off patent in 2017, sold in Italy in 2016. According to data, Rosuvastatina was the branded medicine most popular, with approximately 5.5 million of packages sold. Among the branded drugs, that were about to lose their patent, Bosentan was the one with the lowest number of boxes sold.

本统计数据显示了2016年在意大利销售的、预计将于2017年专利失效的 branded drugs 包装数量。根据数据，Rosuvastatina成为最受欢迎的品牌药物，其销售包装数量约为550万。在即将失去专利的品牌药物中，Bosentan的销售包装数量最少。